Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-16

My broker has spoken to Rohan about the consolidation late last week

it is about packaging it all up better for institutions, both overseas and domestic.

an overseas listing is off the table … because the US funds actually like Australian liquidity and compliance these days, and the process would be such a distraction to the leadership team over the coming 24 months of critical milestones to be delivered.

i do like the sound of all that

Funding options for kidneys program to be reviewed when all the key data in the eyes pipe have been released (timing first half of 2025) and any licensing options from interested groups matured and fully considered.